Study tests drug to shield lungs during cancer surgery in seniors
NCT ID NCT05693246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving glycopyrrolate before and during laparoscopic surgery for gastrointestinal cancer could help maintain lung function in patients aged 65 and older. The drug was tested to see if it could improve oxygen levels and reduce lung injury from mechanical ventilation. The trial involved 52 elderly patients and measured key breathing indicators during and after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the Affiliated Hospital of Yangzhou University, Yangzhou University
Yangzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could common food additives be friend or foe? a massive study investigates
- Can artificial intelligence think like a cancer tumor board?
- Yogurt as medicine? Butyrate-Rich formula tested for Cancer-Related constipation
- New care model aims to close cancer treatment gaps for people with mental illness
- Smartphone app aims to uncover food triggers for gut cancer survivors
- Immunotherapy may let some GI cancer patients skip the knife